GlassScriptPhysician profile
Carrie Staton
NPI 1982649703
$1,095.17
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $714 · 2022: $249 · 2023: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $233.43 | 2021-2022 | |
| Abbvie INC. | $144.54 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.48 | 2022-2023 | |
| Esperion Therapeutics, INC. | $120.00 | 2021 | |
| Lilly USA, LLC | $117.79 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $67.20 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $62.01 | 2021 | |
| Amgen INC. | $47.49 | 2021-2023 | Prolia, Evenity |
| Sanofi-Aventis U.S. LLC | $22.84 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.55 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.58 | 2021 | |
| Lucid Diagnostics INC. | $19.93 | 2023 | |
| Corium, LLC | $19.10 | 2022 | |
| Glaxosmithkline, LLC. | $18.41 | 2021 | |
| Pfizer INC. | $17.74 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.63 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Staton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.